Hormonal
An 8-week Very Low Carbohydrate Diet (VLCD) in older adults with obesity promotes significantly greater loss of visceral adipose tissue (VAT) and intermuscular adipose tissue (IMAT) compared to a standard low-fat diet, while preserving skeletal muscle mass.
If you are an older adult with obesity, switching to a very low-carbohydrate diet (less than 10% of calories from carbs) for 8 weeks can help you lose visceral and intermuscular fat much faster than a standard low-fat diet, without losing your actual muscle mass. You don't need to count calories strictly; simply prioritizing fats and proteins while keeping carbs very low tends to naturally reduce calorie intake and improve insulin sensitivity.
The VLCD group experienced ~ 3-fold greater loss in VAT compared to the LFD group (− 22.8% vs − 1.0%, p < 0.001) and a greater decrease in thigh-IMAT (− 24.4% vs − 1.0%, p < 0.01)... The VLCD group also had significantly greater thigh skeletal muscle (SM) at 8 weeks following adjustment for change in total fat mass.
Why this rating
Randomized clinical trial with objective measures (MRI, clamps), but small sample size (n=34) and short duration (8 weeks).
Source
Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial
Amy M. Goss et al. · Nutrition & Metabolism · 2020
DOI 10.1186/s12986-020-00481-9
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →